Compare GE Vernova Inc (GEV) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE Vernova Inc vs HCA Health Inc — how do they compare? GE Vernova Inc trades at $1,013.51 (market cap $265.56B), while HCA Health Inc trades at $443.69 (market cap $95.08B). The key difference: GE Vernova Inc is far larger — about 2.8× HCA Health Inc's market cap, and HCA Health Inc pays the higher dividend (0.71%). Which is the better fit depends on your goals — on Pluang, investors hold GE Vernova Inc for 36 Days and HCA Health Inc for 76 Days on average.
| GEV | HCA | |
|---|---|---|
Market Cap | $265.56B | $95.08B |
Volume | 1,805,141 | 998,787 |
Sector | Industrials | Health |
52-Week High | $1.17K | $545.13 |
52-Week Low | $547.96 | $361.32 |
Typical Hold Time | 36 Days | 76 Days |
Enterprise Value | $255.23B | $145.62B |
Dividend Yield | 0.2% | 0.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE Vernova (GEV) trades at $997.09, down 3.12% today but maintains strong analyst support with 22 buy ratings and a $1,270 consensus price target. The stock shows bullish technical signals with support at $985 and resistance at $1,005. Recent earnings beat expectations in Q4 2025 and Q1 2026, though Q2 2026 missed estimates. The company benefits from AI-driven power demand growth and secured the first US construction permit for its BWRX-300 small modular reactor.
GEV presents compelling growth potential driven by AI infrastructure demand and nuclear energy expansion, with revenue projected to grow from $38.1B to $41.4B. However, elevated valuation multiples (P/E 28.59, EV/EBITDA 85.02) and execution risks in the wind power segment warrant caution. The strong analyst consensus and 45% YTD gain suggest continued momentum if operational targets are met.
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE Vernova Inc
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
